The Correlations Between Concentrations of Myeloperoxidase, Serum Amyloid-A Protein and Scretory Phospolipase A-2 with Proinflammatory HDL in Healthy Male Person

Marita Kaniawati, Andi Wijaya, Anwar Susanto


BACKGROUND: Low-HDL cholesterol is a risk factor of CAD. Although levels of HDLC are within normal limit in some patients, they suffer CAD. These normal HDL-C levels might become pro-inflammatoric. This study is to measure the correlations between myeloperoxidase (MPO), serum amyloid-A (SAA) protein, and secretoryphospholipase-A2 (sPLA2) with inflammatory status of HDL-C.

METHODS: This was a cross-sectional study recruited 49 subjects with high HDL-C (> 40 mg/dL) and 31 subjects with low HDL-C (< 40 mg/dL). HDL-C was determined into antiinflammatory and proinflammatory based on levels of Apo A-1 and hs-CRP. Concentrations of MPO, SAA and s-PLA2 were measured by ELISA method. Levels of Apo A-1 was determined by immunoturbidimetric method. Multiple logistic regression analysis was done using inflammatory status of HDL-C as dependent variables and levels of MPO, SAA, sPLA2, ages, total cholesterol and triglycerides as independent variables.

RESULTS: Patient’s age was 43.4 + 8.3 year, HDL-C was 43.1 + 9.5 mg/dL, Apo A-1 was 128.3 + 21.5 mg/dL, hs-CRP was 1.92 + 3.0 mg/dL. Concentrations of MPO, SAA and sPLA2 successively were 63.2 + 16.9 ng/mL, 7015.6 + 5021.1 ng/mL and 1340.2 + 406.3 pg/mL. Multiple logistic regression analysis showed that SAA is an independent predictor of pro-inflammatory status of HDL-C in high HDL-C group with prevalence ratio of 11.74 (95% CI : 2.51 – 54.84; P = 0.002). In contrast, MPO and sPLA2 were not independent predictor with PR of 1.26 (95% CI : 0.30 – 5.23; P = 0.75) and of 0.94 (95% CI : 0.23 – 3.91; P = 0.93).

CONCLUSIONS: SAA is an independent predictor of pro-inflammatory HDL-C even in subjects with high HDL-C.

KEYWORDS: Atherosclerosis, Apo A-I, serum amyloid A protein, secretory phospholipase A2, myeloperoxidase

Full Text:



Honey K. Drug designed to raise HDL levels falls down. J Clin Invest. 2007; 117 : 282, CrossRef.

Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, et al. Thematic review series : The pathogenesis of atherosclerosis. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004; 45: 993-1007, CrossRef.

Assmann G, Nofer JR. Atheroprotective effects of high-density lipoproteins. Ann Rev Med. 2004; 54 : 321-41, CrossRef.

Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol. 2003; 23: 1881-8, CrossRef.

Pirro M, Siepi D, Lupattelli G, Roscini AR, Schillaci G, Gemelli F, et al. Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias. Metabolism. 2003, 52: 432-6, CrossRef.

Van Lenten BJ, Hama SY, de Geer FC, Stafforini DM, McIntyre TM, Prescottet SM, et al. Anti-inflammatory HDL becomes proinflammatory during the acute phase ceaction. J Clin Invest. 1995; 96: 2758-67, CrossRef.

Chait A, Han Cy, Oram JF, Heinecke JW. Lipoprotein. Associated inflammatory proteins: markers or mediators of cardiovascular disease? J Lipid Res. 2005; 46: 389-403, CrossRef.

Fogelman AM. When good cholesterol goes bad. Nature Medicine. 2004; 10: 902-3, CrossRef.

Zheng L, Nukuna B, Brennan M, Sun M, Goormastic M, Settle M, et al. Apoliprotein A-1 is a selective target for myeloperoxidase, catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest. 2004; 114: 529-41, CrossRef.

Bergt C, Pennathur S, Fu X, Byun J, O'Brien K, McDonald TO, et al. The myceoperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABC-A1 dependent cholesterol transport. PNAS. 2004; 101: 13032-7, CrossRef.

Hosoai H, Webb NR, Glick JM, Tietge UJ, Purdom MS, de Beer FC, et al. Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL-cholesterol or Apo A-1 levels in human, Apo A-1 transgenic mice. J. Lipid Res 1999; 40: 648-653, PMID.

Rohrer L, Hersberger M, Eckardstein A. High Density Lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol. 2004; 15: 269-78, CrossRef.


Indexed by:






The Prodia Education and Research Institute